Factor-8 and Factor-9 Deficient Plasmas
Factor-8 and Factor-9 Deficient Plasmas
Helena’s high-quality factor deficient plasmas are trusted worldwide by pharmaceutical and government customers, offering a reliable method for the quality control of haemophilia treatment products.
Congenitally deficient plasmas ensure presence of naturally associated proteins (for example Von Willebrand Factor)
Provides more accurate factor deficiency clotting time
Residual factor activity of less than 1%
Available guaranteed HiV and Hepatitis-negative
Long-term shelf life and stability
Factor VIII and Factor IX Deficient Plasmas are widely used for the quality control of Haemophilia A and Haemophilia B treatment products. Our congenital plasmas are sourced from naturally-deficient human donors and do not suffer from the removal of other proteins which can occur with immunodepleted products.
Helena Biosciences offer a full range of Factor Deficient Plasmas in both congenital and immunodepleted formats, and our plasmas are available as guaranteed HIV and Hepatitis-negative.